SCOR Investment Partners, the SCOR group’s portfolio management company, announces the end of the deployment of EUR 378 million, which have been raised throughout the marketing of the SCOR infrastructure Loans II fund
In a new inFORM publication, SCOR Life division experts Dephine Labojka and Dr. James Kadouch discuss the most common heart valve diseases, their etiology, and the efficiency of surgery.
SCOR is a signatory of the French Business Climate Pledge, through which 89 French companies commit to taking concrete action to drastically reduce greenhouse gas emissions.
Winner of the 2017 Actuarial Award in Germany
Winner of the 2017 Actuarial Award in Germany
Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
Die Prävalenz von Herzklappenerkrankungen in der Allgemeinbevölkerung ist mit ungefähr 2,5% niedrig. Bei den über 75-Jährigen liegt sie mit 10-15% wesentlich höher
Winner of the 2017 Actuarial Award in Germany
Winner of the 2017 Actuarial Award in the United Kingdom
During her presentation titled “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Conference 2017, Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life, add
Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
Presentation of Daria Ossipova about “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Annual Conference SCOR.
